Latest news and research on all cancers and treatments, updated several times a week
18 edition of the scientific journal Immunity, mark a turning point in cancer ... The puzzle has hampered efforts to harness the immune system to fight ...
The human part of the study was much more limited: a group of cancer patients fasted for 1, 2, or 3 days prior to chemotherapy. The idea is that fasting ...
... immunotherapy that causes the immune system to generate cancer-fighting ... Gastric cancer is the second leading cause of cancer mortality and the ...
... sequencing (NGS), for their ability to detect and characterize the presence of bladder cancer DNA in urine as well as breast cancer DNA in blood.
Skyline currently has active trials involving new oral or IV drugs to treat advanced prostate cancer, bladder cancer and overactive bladder.
Cancer News in Science Daily
A two-pronged therapeutic approach has been discovered that shows great potential for weakening and then defeating cancer cells. The research team's complex mix of genetic and biochemical experiments unearthed a way to increase the presence of a tumor-suppressing protein which, in turn, gives it the strength to direct cancer cells toward a path that leads to their destruction.
Neonatal HBV vaccination reduces the risk of liver cancer and other liver diseases in young adults in China, according to a study. By collecting data on new cases of liver diseases over 30 years from a population-based tumor registry, the researchers estimated that the protective efficacy of vaccination was 84% for primary liver cancer (vaccination reduced the incidence of liver cancer by 84%), 70% for death from liver diseases, and 69% for the incidence of infant fulminant hepatitis.
A new study supports the hypothesis that lung cancer, particularly adenocarcinoma, may spread through the airways. The putative occurrence of intrapulmonary aerogenous metastasis of lung cancer has staging, management, and prognostic implications.
A recent article describes clinical trials that match drugs to long-overlooked oncogene, TRK, offering targeted treatment options for cancers that harbor these gene abnormalities. The TRK family of genes, including NTRK1, NTRK2 and NTRK3 are important in the developing nervous system. In the womb, these genes and the proteins they encode are essential for the growth and survival of new neurons. After birth, these genes are unneeded in many tissues and so are programmed to go dormant, however, experts have learned that some cancers wake them up.
Tambahkan Komentar